Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Irina Proskorovsky

Showing results (1-10 of 34) with videos related to

Pageof 4
Sort By:
Research Synthesis Methods|September 26, 2024
Uncertain about uncertainty in matching-adjusted indirect comparisons? A simulation study to compare methods for variance estimationConor O Chandler, Irina Proskorovsky
Pharmacoeconomics|March 22, 2015
Simulation and matching-based approaches for indirect comparison of treatmentsK Jack Ishak, Irina Proskorovsky, Agnes Benedict
Clinical Therapeutics|January 11, 2007
Compliance with refilling prescriptions for atypical antipsychotic agents and its association with the risks for hospitalization, suicide, and death in patients with schizophrenia in Quebec and Saskatchewan: a retrospective database studyAlexandra Ward, Khajak Ishak, Irina Proskorovsky, et al.
BMC Cardiovascular Disorders|June 24, 2005
The morbidity and mortality following a diagnosis of peripheral arterial disease: long-term follow-up of a large databaseJaime Caro, Kristen Migliaccio-Walle, Khajak J Ishak, et al.
Multiple Sclerosis and Related Disorders|April 12, 2016
Assessing the impact of multiple sclerosis disease activity and daclizumab HYP treatment on patient-reported outcomes: Results from the SELECT trialGlenn Phillips, Shien Guo, Randall Bender, et al.
BMC Health Services Research|December 30, 2011
Lifetime economic burden of prostate cancerMichael E Stokes, Jack Ishak, Irina Proskorovsky, et al.
Liver Cancer|June 16, 2023
Regorafenib versus Cabozantinib as a Second-Line Treatment for Advanced Hepatocellular Carcinoma: An Anchored Matching-Adjusted Indirect Comparison of Efficacy and SafetyPhilippe Merle, Masatoshi Kudo, Stanimira Krotneva, et al.
BMC Cardiovascular Disorders|September 4, 2010
Evaluation of the consequences associated with diffuse vascular disease history in patients diagnosed with peripheral arterial disease: estimates from Saskatchewan health dataKristen Migliaccio-Walle, Michael Stokes, Irina Proskorovsky, et al.
Pharmacoeconomics|March 6, 2014
Methods for adjusting for bias due to crossover in oncology trialsK Jack Ishak, Irina Proskorovsky, Beata Korytowsky, et al.
BMC Health Services Research|August 16, 2006
The time course of subsequent hospitalizations and associated costs in survivors of an ischemic stroke in CanadaJ Jaime Caro, Kristen Migliaccio-Walle, Khajak J Ishak, et al.
Pageof 4

Showing results (1-10 of 34) with videos related to

Sort By:
Pageof 4
Research Synthesis Methods|September 26, 2024
Uncertain about uncertainty in matching-adjusted indirect comparisons? A simulation study to compare methods for variance estimationConor O Chandler, Irina Proskorovsky
Pharmacoeconomics|March 22, 2015
Simulation and matching-based approaches for indirect comparison of treatmentsK Jack Ishak, Irina Proskorovsky, Agnes Benedict
Clinical Therapeutics|January 11, 2007
Compliance with refilling prescriptions for atypical antipsychotic agents and its association with the risks for hospitalization, suicide, and death in patients with schizophrenia in Quebec and Saskatchewan: a retrospective database studyAlexandra Ward, Khajak Ishak, Irina Proskorovsky, et al.
BMC Cardiovascular Disorders|June 24, 2005
The morbidity and mortality following a diagnosis of peripheral arterial disease: long-term follow-up of a large databaseJaime Caro, Kristen Migliaccio-Walle, Khajak J Ishak, et al.
Multiple Sclerosis and Related Disorders|April 12, 2016
Assessing the impact of multiple sclerosis disease activity and daclizumab HYP treatment on patient-reported outcomes: Results from the SELECT trialGlenn Phillips, Shien Guo, Randall Bender, et al.
BMC Health Services Research|December 30, 2011
Lifetime economic burden of prostate cancerMichael E Stokes, Jack Ishak, Irina Proskorovsky, et al.
Liver Cancer|June 16, 2023
Regorafenib versus Cabozantinib as a Second-Line Treatment for Advanced Hepatocellular Carcinoma: An Anchored Matching-Adjusted Indirect Comparison of Efficacy and SafetyPhilippe Merle, Masatoshi Kudo, Stanimira Krotneva, et al.
BMC Cardiovascular Disorders|September 4, 2010
Evaluation of the consequences associated with diffuse vascular disease history in patients diagnosed with peripheral arterial disease: estimates from Saskatchewan health dataKristen Migliaccio-Walle, Michael Stokes, Irina Proskorovsky, et al.
Pharmacoeconomics|March 6, 2014
Methods for adjusting for bias due to crossover in oncology trialsK Jack Ishak, Irina Proskorovsky, Beata Korytowsky, et al.
BMC Health Services Research|August 16, 2006
The time course of subsequent hospitalizations and associated costs in survivors of an ischemic stroke in CanadaJ Jaime Caro, Kristen Migliaccio-Walle, Khajak J Ishak, et al.
Pageof 4